Teladoc (TDOC) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Teladoc (TDOC) reported revenue of $626.44 million, down 2.2% over the same period last year. EPS came in at -$0.21, compared to -$0.19 in the year-ago quarter.The reported revenue represents a surprise of +0.23% over the Zacks Consensus Estimate of $625.02 million. With the consensus EPS estimate being -$0.26, the EPS surprise was +19.23%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Teladoc performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Average Monthly Revenue Per U.S. Integrated Care Member: $1.27 versus $1.27 estimated by five analysts on average.BetterHelp Paying Users: 0.38 million versus 0.39 million estimated by five analysts on average.U.S. Integrated Care Members: 102.5 million versus the five-analyst average estimate of 102.26 million.Chronic Care Program Enrollment: 1.17 million versus 1.16 million estimated by four analysts on average.Revenues by Segment- Integrated Care: $389.54 million versus $388.13 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +1.5% change.Revenues by Segment- BetterHelp: $236.9 million compared to the $237.7 million average estimate based on seven analysts. The reported number represents a change of -7.8% year over year.Revenues by Segment- BetterHelp- Other Wellness Services: $5.1 million compared to the $5.28 million average estimate based on three analysts. The reported number represents a change of -18.5% year over year.Revenues by Segment- BetterHelp- Therapy Services: $231.8 million versus $231.99 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -7.5% change.Revenue by Type- Other: $105.53 million versus the two-analyst average estimate of $90.63 million. The reported number represents a year-over-year change of +23.8%.Revenue by Type- Access fees: $520.91 million versus $533.92 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -6.2% change.Adjusted EBITDA- BetterHelp: $3.84 million compared to the $8.46 million average estimate based on five analysts.Adjusted EBITDA- Integrated Care: $66.07 million versus the five-analyst average estimate of $59.01 million.View all Key Company Metrics for Teladoc here>>>Shares of Teladoc have returned +8.2% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Teladoc Health, Inc. (TDOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks